Role of subclinical primary hyperaldosteronism on heart remodelling assessed by echocardiography: a population-based cohort study

Back

ESC2025 Premium Access

Role of subclinical primary hyperaldosteronism on heart remodelling assessed by echocardiography: a population-based cohort study

Session: Cardiovascular risk assessment: biomarkers (2)

Topic: Biomarkers

Speaker: Mr A. Angelico-Goncalves (Vila Nova de Gaia, PT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Mr Antonio Angelico-Goncalves

Hospital Center of Vila Nova de Gaia/Espinho, Vila Nova de Gaia (Portugal)

0 follower

4 more presentations in this session

Predicting postoperative myocardial infarction in noncardiac surgery patients using explainable artificial intelligence

Speaker: Mr B. Arends (Utrecht, NL)

Ceramides surpass LDL-cholesterol in predicting cardiovascular mortality in patients with as well as in patients without the metabolic syndrome

Speaker: Doctor A. Mader (Feldkirch, AT)

Associations between an insulin resistance guide, the triglyceride glucose index (TyG) and subclinical atherosclerosis progression in a coronary population

Speaker: Doctor G. Bettencourt Abreu (Funchal, PT)

Causal associations between hypothyroidism and cardiovascular diseases: a Mendelian randomization study

Speaker: Mr L. Jiang (Nanjing, CN)

Access the full session

Cardiovascular risk assessment: biomarkers (2)

Speakers: Mr A. Angelico-Goncalves, Mr B. Arends, Doctor A. Mader, Doctor G. Bettencourt Abreu, Mr L. Jiang

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources